GTS5:PALB2-related cancer predisposition syndrome (PALB2): Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
Kgeiersbach (talk | contribs) No edit summary |
||
| Line 54: | Line 54: | ||
Put your text here <span style="color:#0070C0">(''Instructions: Include a brief general clinical description, diagnostic criteria, and differential diagnosis if applicable. Include disease context relative to other WHO classification categories, i.e. describe any information relevant to the genetic aspects of the disease from all WHO classification books in which the syndrome is described.'')</span> | Put your text here <span style="color:#0070C0">(''Instructions: Include a brief general clinical description, diagnostic criteria, and differential diagnosis if applicable. Include disease context relative to other WHO classification categories, i.e. describe any information relevant to the genetic aspects of the disease from all WHO classification books in which the syndrome is described.'')</span> | ||
- Function: | - Function: The PALB2 gene at 16p12.1 encodes for a protein that binds to the BRCA2 protein as part of the DNA damage response pathway. More specifically, PALB2 protein is a component of the homologous recombination complex machinery responsible for repairing double-strand DNA breaks. PALB2 functions as a tumor-suppressor in the homologous recombination repair pathway to maintain genome integrity. | ||
- | - | ||